KPTI - Karyopharm Therapeutics GAAP EPS of -$0.32 beats by $0.03 revenue of $33.13M misses by $1.34M
2024-05-08 07:33:56 ET
More on Karyopharm Therapeutics
- Karyopharm Therapeutics: Spiraling Despite Upcoming Catalysts
- Karyopharm Therapeutics Inc. (KPTI) Q4 2023 Earnings Call Transcript
- Karyopharm Therapeutics Inc. 2023 Q4 - Results - Earnings Call Presentation
- Karyopharm Therapeutics Q1 2024 Earnings Preview
- Karyopharm Therapeutics GAAP EPS of -$0.36 misses by $0.07, revenue of $33.7M beats by $0.08M